These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 8520877)
41. Granisetron versus granisetron/dexamethasone combination for the treatment of nausea, retching, and vomiting after major gynecologic surgery: a randomized, double-blind study. Fujii Y; Tanaka H Clin Ther; 2003 Feb; 25(2):507-14. PubMed ID: 12749510 [TBL] [Abstract][Full Text] [Related]
42. Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. Italian Group for Antiemetic Research N Engl J Med; 1995 Jan; 332(1):1-5. PubMed ID: 7990859 [TBL] [Abstract][Full Text] [Related]
43. Review of the preclinical pharmacology and comparative efficacy of 5-hydroxytryptamine-3 receptor antagonists for chemotherapy-induced emesis. Perez EA J Clin Oncol; 1995 Apr; 13(4):1036-43. PubMed ID: 7707101 [TBL] [Abstract][Full Text] [Related]
44. The control of acute cisplatin-induced emesis--a comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone. Granisetron Study Group. Chevallier B Br J Cancer; 1993 Jul; 68(1):176-80. PubMed ID: 8391304 [TBL] [Abstract][Full Text] [Related]
45. Randomized, double-blind comparison of granisetron versus granisetron plus prednisolone as antiemetic prophylaxis during multiple-day cisplatin-based chemotherapy. Handberg J; Wessel V; Larsen L; Herrstedt J; Hansen HH Support Care Cancer; 1998 Jan; 6(1):63-7. PubMed ID: 9458539 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of Antiemetic Therapy for Hepatic Transcatheter Arterial Infusion Chemotherapy with Cisplatin. Hashizume J; Higuchi N; Sato K; Kodama Y; Matsunaga N; Sakamoto T; Yamaguchi K; Nakamura T; Kitahara T; Sasaki H Biol Pharm Bull; 2016; 39(4):611-4. PubMed ID: 27040634 [TBL] [Abstract][Full Text] [Related]
47. [A randomized crossover comparison of azasetron and granisetron in the prophylaxis of emesis induced by chemotherapy including cisplatin]. Tsukuda M; Mochimatsu I; Furukawa M; Kohno H; Kawai S; Enomoto H; Yago T; Matsuda H; Ikema Y; Zhou L Gan To Kagaku Ryoho; 1995 Nov; 22(13):1959-67. PubMed ID: 7487127 [TBL] [Abstract][Full Text] [Related]
48. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869. Van Belle S; Lichinitser MR; Navari RM; Garin AM; Decramer ML; Riviere A; Thant M; Brestan E; Bui B; Eldridge K; De Smet M; Michiels N; Reinhardt RR; Carides AD; Evans JK; Gertz BJ Cancer; 2002 Jun; 94(11):3032-41. PubMed ID: 12115394 [TBL] [Abstract][Full Text] [Related]
49. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis. Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907 [TBL] [Abstract][Full Text] [Related]
50. 5-HT3 receptor antagonists in the control of cisplatin-induced delayed emesis. Ossi M; Anderson E; Freeman A Oncology; 1996 Jun; 53 Suppl 1():78-85. PubMed ID: 8692556 [TBL] [Abstract][Full Text] [Related]
51. Randomized, double-blind, dose-finding study of dexamethasone in preventing acute emesis induced by anthracyclines, carboplatin, or cyclophosphamide: Italian Group For Antiemetic Research J Clin Oncol; 2004 Feb; 22(4):725-9. PubMed ID: 14966097 [TBL] [Abstract][Full Text] [Related]
52. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban). Morrow GR; Hickok JT; Rosenthal SN Cancer; 1995 Aug; 76(3):343-57. PubMed ID: 8625113 [TBL] [Abstract][Full Text] [Related]
53. A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. The Granisetron Study Group. Marty M Eur J Cancer; 1990; 26 Suppl 1():S28-32. PubMed ID: 2169783 [TBL] [Abstract][Full Text] [Related]
54. Cisplatin-induced emesis in the cat: effect of granisetron and dexamethasone. Rudd JA; Tse JY; Wai MK Eur J Pharmacol; 2000 Mar; 391(1-2):145-50. PubMed ID: 10720646 [TBL] [Abstract][Full Text] [Related]
55. Multicenter, randomized trial of ramosetron plus dexamethasone versus ramosetron alone in controlling cisplatin-induced emesis. Villalon A; Chan V Support Care Cancer; 2004 Jan; 12(1):58-63. PubMed ID: 14655041 [TBL] [Abstract][Full Text] [Related]
56. Tropisetron and dexamethasone administered twice daily for the prevention of acute emesis in patients treated with continuous infusion of Cisplatin-Doxorubicin and high-dose Ifosfamide over 48, 24, and 120 hours. Forni C; Loro L; Mazzei T; Beghelli C; Biolchini A; Tremosini M; Triggiani A; Bacci G Cancer Nurs; 2003 Aug; 26(4):331-4. PubMed ID: 12886124 [TBL] [Abstract][Full Text] [Related]
57. A double-blind, crossover, randomized comparison of granisetron and ramosetron for the prevention of acute and delayed cisplatin-induced emesis in patients with gastrointestinal cancer: is patient preference a better primary endpoint? Koizumi W; Tanabe S; Nagaba S; Higuchi K; Nakayama N; Saigenji K; Nonaka M; Yago K Chemotherapy; 2003 Dec; 49(6):316-23. PubMed ID: 14671433 [TBL] [Abstract][Full Text] [Related]
58. A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis. Aapro MS; Thuerlimann B; Sessa C; De Pree C; Bernhard J; Maibach R; Ann Oncol; 2003 Feb; 14(2):291-7. PubMed ID: 12562658 [TBL] [Abstract][Full Text] [Related]
59. Comparison of intravenous granisetron with metoclopramide in the treatment of chemotherapy-induced emesis. Chiou TJ; Wei CH; Hsieh RK; Fan FS; Liu JH; Chen PM Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jul; 56(1):23-30. PubMed ID: 7553406 [TBL] [Abstract][Full Text] [Related]